Enhancing healthcare economics: the impact of manual dose rounding on T-DM1 costs in breast cancer treatment
2026 · Drugs & Therapy Perspectives · 0 citations
https://doi.org/10.1007/s40267-026-01219-y
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
1
Papers
0
Citations
0
h-index
0
i10-index
Riikka-Liisa Vuorinen is an academic researcher from Tampere University. The author has contributed to research in topics: HER2/EGFR in Cancer Research & Advanced Breast Cancer Therapies & Safe Handling of Antineoplastic Drugs.
Click to start Chat